163 related articles for article (PubMed ID: 9352600)
21. Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.
Chaturvedi P; Qin HY; Chou H; Singh B
Crit Rev Immunol; 1997; 17(5-6):519-28. PubMed ID: 9419439
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
Nossal GJ; Herold KC; Goodnow CC
Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
[TBL] [Abstract][Full Text] [Related]
23. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells.
O'Sullivan BJ; Thomas HE; Pai S; Santamaria P; Iwakura Y; Steptoe RJ; Kay TW; Thomas R
J Immunol; 2006 Jun; 176(12):7278-87. PubMed ID: 16751371
[TBL] [Abstract][Full Text] [Related]
24. Persistent T cell anergy in human type 1 diabetes.
Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ
J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096
[TBL] [Abstract][Full Text] [Related]
25. Overcoming tolerance in autoimmune renal disease.
Heeger PS; Neilson EG
Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):123-32. PubMed ID: 7842261
[No Abstract] [Full Text] [Related]
26. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
27. Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance.
Jacobs MJ; van den Hoek AE; van de Putte LB; van den Berg WB
Immunology; 1994 Jun; 82(2):294-300. PubMed ID: 7523288
[TBL] [Abstract][Full Text] [Related]
28. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
Arreaza GA; Cameron MJ; Jaramillo A; Gill BM; Hardy D; Laupland KB; Rapoport MJ; Zucker P; Chakrabarti S; Chensue SW; Qin HY; Singh B; Delovitch TL
J Clin Invest; 1997 Nov; 100(9):2243-53. PubMed ID: 9410902
[TBL] [Abstract][Full Text] [Related]
29. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
Jewell SD; Gienapp IE; Cox KL; Whitacre CC
Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy of allergy: anergy, deletion, and immune deviation.
Rolland J; O'Hehir R
Curr Opin Immunol; 1998 Dec; 10(6):640-5. PubMed ID: 9914222
[TBL] [Abstract][Full Text] [Related]
31. Anergic B cells caught in the act.
Melchers F
Immunity; 2006 Dec; 25(6):864-7. PubMed ID: 17174929
[TBL] [Abstract][Full Text] [Related]
32. The role of anergy in peripheral T cell unresponsiveness.
Johnson JG; Jenkins MK
Life Sci; 1994; 55(23):1767-80. PubMed ID: 7968257
[TBL] [Abstract][Full Text] [Related]
33. mTOR at the crossroads of T cell proliferation and tolerance.
Mondino A; Mueller DL
Semin Immunol; 2007 Jun; 19(3):162-72. PubMed ID: 17383196
[TBL] [Abstract][Full Text] [Related]
34. Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats.
Lundin BS; Dahlgren UI; Hanson LA; Telemo E
Scand J Immunol; 1996 Jan; 43(1):56-63. PubMed ID: 8560197
[TBL] [Abstract][Full Text] [Related]
35. The role of clonal anergy in the avoidance of autoimmunity: inactivation of autocrine growth without loss of effector function.
Malvey EN; Telander DG; Vanasek TL; Mueller DL
Immunol Rev; 1998 Oct; 165():301-18. PubMed ID: 9850869
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy--anergy, deviation or suppression?
Smith W; Sly PD
Clin Exp Allergy; 1998 Aug; 28(8):911-6. PubMed ID: 9756192
[No Abstract] [Full Text] [Related]
37. Adaptive tolerance and clonal anergy are distinct biochemical states.
Chiodetti L; Choi S; Barber DL; Schwartz RH
J Immunol; 2006 Feb; 176(4):2279-91. PubMed ID: 16455984
[TBL] [Abstract][Full Text] [Related]
38. Balancing immunity, autoimmunity, and self-tolerance.
Goodnow CC
Ann N Y Acad Sci; 1997 Apr; 815():55-66. PubMed ID: 9186639
[No Abstract] [Full Text] [Related]
39. Autoimmune diabetes: how many steps for one disease?
Bach JF; Chatenoud L; Herbelin A; Gombert JM; Carnaud C
Res Immunol; 1997 Jun; 148(5):332-8. PubMed ID: 9352598
[No Abstract] [Full Text] [Related]
40. New strategies in oral immunotherapy for diabetes prevention.
Muir A; Ramiya V
Diabetes Metab Rev; 1996 Apr; 12(1):1-14. PubMed ID: 8861498
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
